Equity has made over 1 trades of the GoodRx stock since 2024, according to the Form 4 filled with the SEC. Most recently Equity sold 10,677 units of GDRX stock worth $83,921 on 29 August 2024.
The largest trade Equity's ever made was selling 10,677 units of GoodRx stock on 29 August 2024 worth over $83,921. On average, Equity trades about 3,559 units every 0 days since 2023.
You can see the complete history of Equity Vi stock trades at the bottom of the page.
Over the last 4 years, insiders at GoodRx have traded over $678,425,284 worth of GoodRx stock and bought 1,817,103 units worth $61,013,097 . The most active insiders traders include Capital Management, Llc Abd..., Men, Llc Idea és Stephen Spectrum Vii Invest.... On average, GoodRx executives and independent directors trade stock every 11 days with the average trade being worth of $1,330,718. The most recent stock trade was executed by Romin Nabiey on 8 September 2024, trading 12,433 units of GDRX stock currently worth $93,123.
GoodRx Holdings, Inc., through its subsidiaries, provides information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including telehealth services. The company serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.
GoodRx executives and other stock owners filed with the SEC include: